#  October 16, 2023: Faculty Chat with Dr. Aaron Kesselheim 

 



 ##  

  expand\_more  

 
  

 

 Dr. Aaron Kesselheim (MD, JD, MPH) created and leads the Brigham and Women’s Hospital’s Program On Regulation, Therapeutics, And Law (PORTAL). [He recently testified to Congress (click to watch testimony)](https://energycommerce.house.gov/events/oversight-and-investigations-subcommittee-hearing-1) regarding the 2022 Inflation Reduction Act’s provisions for prescription drugs, including new mechanisms enabling the government to negotiate drug prices.

 **Please join us for a casual discussion** on these policies, how they’re shaping the drugmaking industry, and their potential impact on healthcare innovation, access, and quality.

 ![aaron poster](/sites/g/files/omnuum9646/files/sciencepolicy/files/screenshot_2023-10-10_at_9.31.24_am.png)